Cargando…

Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea

Antimicrobial drug treatment of travelers’ diarrhea is known to increase the risk for colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae. Among 288 travelers with travelers’ diarrhea, the colonization rate without medications was 21%. For treatment with loperamide only, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kantele, Anu, Mero, Sointu, Kirveskari, Juha, Lääveri, Tinja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696706/
https://www.ncbi.nlm.nih.gov/pubmed/26691898
http://dx.doi.org/10.3201/eid2201.151272
_version_ 1782407819223367680
author Kantele, Anu
Mero, Sointu
Kirveskari, Juha
Lääveri, Tinja
author_facet Kantele, Anu
Mero, Sointu
Kirveskari, Juha
Lääveri, Tinja
author_sort Kantele, Anu
collection PubMed
description Antimicrobial drug treatment of travelers’ diarrhea is known to increase the risk for colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae. Among 288 travelers with travelers’ diarrhea, the colonization rate without medications was 21%. For treatment with loperamide only, the rate was 20%; with antimicrobial drugs alone, 40%; and with loperamide and antimicrobial drugs, 71%.
format Online
Article
Text
id pubmed-4696706
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-46967062016-01-05 Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea Kantele, Anu Mero, Sointu Kirveskari, Juha Lääveri, Tinja Emerg Infect Dis Dispatch Antimicrobial drug treatment of travelers’ diarrhea is known to increase the risk for colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae. Among 288 travelers with travelers’ diarrhea, the colonization rate without medications was 21%. For treatment with loperamide only, the rate was 20%; with antimicrobial drugs alone, 40%; and with loperamide and antimicrobial drugs, 71%. Centers for Disease Control and Prevention 2016-01 /pmc/articles/PMC4696706/ /pubmed/26691898 http://dx.doi.org/10.3201/eid2201.151272 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Kantele, Anu
Mero, Sointu
Kirveskari, Juha
Lääveri, Tinja
Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea
title Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea
title_full Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea
title_fullStr Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea
title_full_unstemmed Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea
title_short Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea
title_sort increased risk for esbl-producing bacteria from co-administration of loperamide and antimicrobial drugs for travelers’ diarrhea
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696706/
https://www.ncbi.nlm.nih.gov/pubmed/26691898
http://dx.doi.org/10.3201/eid2201.151272
work_keys_str_mv AT kanteleanu increasedriskforesblproducingbacteriafromcoadministrationofloperamideandantimicrobialdrugsfortravelersdiarrhea
AT merosointu increasedriskforesblproducingbacteriafromcoadministrationofloperamideandantimicrobialdrugsfortravelersdiarrhea
AT kirveskarijuha increasedriskforesblproducingbacteriafromcoadministrationofloperamideandantimicrobialdrugsfortravelersdiarrhea
AT laaveritinja increasedriskforesblproducingbacteriafromcoadministrationofloperamideandantimicrobialdrugsfortravelersdiarrhea